InvestorsHub Logo
Post# of 4972560
Next 10
Followers 2732
Posts 55279
Boards Moderated 4
Alias Born 08/10/2012

Re: None

Tuesday, 05/03/2022 10:47:36 AM

Tuesday, May 03, 2022 10:47:36 AM

Post# of 4972560
$RXMD Key Financial Highlights for Year Ended December 31, 2021

• Revenue at $38.9 million

- COVID-19 testing revenue of approximately $4.3 million

- ClearMetrX TPA and pharmacy dispensing revenue related to 340B earned $2.8 million on total billings of $19 million

• Gross margin increased to 26% in 2021, from 23% in 2020

• EBITDA increased to $167,000 in 2021 from $7,000 in 2020

• Cash balance of $1.4 million as of December 31, 2021


https://www.otcmarkets.com/stock/RXMD/news/Progressive-Care-Reports-Full-Year-2021-Financial-Results-Highlighted-by-389-Million-in-Revenue?id=349785

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.